Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Begier

Showing results (31-40 of 132) with videos related to

Pageof 14
Sort By:
Infection Control and Hospital Epidemiology|March 11, 2022
<i>Staphylococcus aureus</i> infections after elective pediatric surgeriesIona M Munjal, Jill Dreyfus, Holly Yu, et al.
American Journal of Public Health|October 24, 2013
Programmatic impact of 5 years of mortality surveillance of New York City homeless populationsMelissa Gambatese, Dova Marder, Elizabeth Begier, et al.
Infectious Diseases and Therapy|March 21, 2023
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling StudyYou Li, Durga Kulkarni, Elizabeth Begier, et al.
BMC Pulmonary Medicine|October 4, 2024
Immediate post-discharge care among US adults hospitalized with respiratory syncytial virus infectionReiko Sato, Jen Judy, Kari Yacisin, et al.
Infectious Diseases and Therapy|May 5, 2026
Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?S Elizabeth Williams, Giovanni Checcucci Lisi, Kate Luisi, et al.
Infectious Diseases and Therapy|January 29, 2026
Outpatient RSV Testing Rates Among US Adults with Lower Respiratory Tract Disease, 2017-2024Katherine K Perez, Kashmira Date, Negar Aliabadi, et al.
Infectious Diseases and Therapy|July 6, 2024
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive MeasuresCharles Nuttens, Juliette Moyersoen, Daniel Curcio, et al.
Infectious Diseases and Therapy|March 19, 2024
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis ProtocolRobin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
Open Forum Infectious Diseases|November 30, 2023
Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income CountriesAnnete Njue, Weyinmi Nuabor, Matthew Lyall, et al.
Vaccines|February 26, 2026
Vaccination Strategies Against Respiratory Pathogens in the Adult Population: A Narrative ReviewLaura E Sarabia, Elizabeth Williams, Kashmira Date, et al.
Pageof 14

Showing results (31-40 of 132) with videos related to

Sort By:
Pageof 14
Infection Control and Hospital Epidemiology|March 11, 2022
<i>Staphylococcus aureus</i> infections after elective pediatric surgeriesIona M Munjal, Jill Dreyfus, Holly Yu, et al.
American Journal of Public Health|October 24, 2013
Programmatic impact of 5 years of mortality surveillance of New York City homeless populationsMelissa Gambatese, Dova Marder, Elizabeth Begier, et al.
Infectious Diseases and Therapy|March 21, 2023
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling StudyYou Li, Durga Kulkarni, Elizabeth Begier, et al.
BMC Pulmonary Medicine|October 4, 2024
Immediate post-discharge care among US adults hospitalized with respiratory syncytial virus infectionReiko Sato, Jen Judy, Kari Yacisin, et al.
Infectious Diseases and Therapy|May 5, 2026
Adult RSV Vaccination: What Is the Role of RSV Subgroup in Disease Prevention?S Elizabeth Williams, Giovanni Checcucci Lisi, Kate Luisi, et al.
Infectious Diseases and Therapy|January 29, 2026
Outpatient RSV Testing Rates Among US Adults with Lower Respiratory Tract Disease, 2017-2024Katherine K Perez, Kashmira Date, Negar Aliabadi, et al.
Infectious Diseases and Therapy|July 6, 2024
Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive MeasuresCharles Nuttens, Juliette Moyersoen, Daniel Curcio, et al.
Infectious Diseases and Therapy|March 19, 2024
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis ProtocolRobin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
Open Forum Infectious Diseases|November 30, 2023
Systematic Literature Review of Risk Factors for Poor Outcomes Among Adults With Respiratory Syncytial Virus Infection in High-Income CountriesAnnete Njue, Weyinmi Nuabor, Matthew Lyall, et al.
Vaccines|February 26, 2026
Vaccination Strategies Against Respiratory Pathogens in the Adult Population: A Narrative ReviewLaura E Sarabia, Elizabeth Williams, Kashmira Date, et al.
Pageof 14